Journalist
Lee Hyo-jeong
hyo@ajunews.com
-
Samsung Biologics Q1 revenue tops 1.2 trillion won; operating profit 580.8 billion won April 22, 2026
-
Pharos iBio Presents Next-Gen Cancer Drug Data at AACR, Targets Global Market April 22, 2026
-
Samsung Biologics Faces Strike Threat as Court Ruling Looms April 21, 2026
-
Samsung Bioepis Unveils Preclinical Data on First New Cancer Drug Candidate at AACR 2026 April 21, 2026
-
Samsung Biologics Makes Debut at AACR, Targeting Early-Stage Oncology Clients April 20, 2026
-
Korean Drugmakers Head to AACR 2026 to Showcase Next-Gen Cancer Research April 17, 2026
-
Hanmi Launches Task Force to Commercialize Obesity Drug Efpeglenatide; Other Pharma-Bio Updates April 17, 2026
-
Lotte Biologics to Present SoluFlex Link ADC Platform Data at AACR 2026 April 15, 2026
-
Korean Drugmakers Reshape R&D as Price Cuts and Commercial Law Changes Loom April 14, 2026
-
Centrum Cites Long-Term Research on Brain Health and Healthy Aging, Expands Korea Strategy April 14, 2026
